Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
529K
-
Shares change
-
+851
-
Total reported value, excl. options
-
$1.51M
-
Value change
-
+$2.46K
-
Number of buys
-
7
-
Number of sells
-
-4
-
Price
-
$2.85
Significant Holders of Lipocine Inc. - COM NEW (LPCN) as of Q3 2025
21 filings reported holding LPCN - Lipocine Inc. - COM NEW as of Q3 2025.
Lipocine Inc. - COM NEW (LPCN) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 529K shares
.
Largest 10 shareholders include VANGUARD GROUP INC (222K shares), BlackRock, Inc. (89.3K shares), GEODE CAPITAL MANAGEMENT, LLC (61.1K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (46.8K shares), RENAISSANCE TECHNOLOGIES LLC (36.1K shares), STATE STREET CORP (18.6K shares), CITADEL ADVISORS LLC (14.2K shares), NORTHERN TRUST CORP (13.2K shares), DIMENSIONAL FUND ADVISORS LP (12.1K shares), and BARCLAYS PLC (9.41K shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.